Published in PLoS One on July 31, 2015
DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome. Front Behav Neurosci (2016) 0.79
An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome. PLoS One (2016) 0.77
The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome. Front Cell Neurosci (2017) 0.75
Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome. Neurobiol Dis (2017) 0.75
Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from Down syndrome and mouse models. Epigenomics (2016) 0.75
A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet (1995) 4.95
A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science (2004) 4.16
Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci (2007) 3.74
Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nat Protoc (2006) 3.71
An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science (2005) 3.61
Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron (2006) 3.51
Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can J Psychiatry (2006) 2.79
Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology (Berl) (2009) 2.76
Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J Neurosci (2004) 2.73
Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci U S A (1998) 2.32
Segmental trisomy as a mouse model for Down syndrome. Prog Clin Biol Res (1993) 2.29
Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome. Hum Mol Genet (2001) 2.24
Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res (1994) 2.20
Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav (1991) 2.04
Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome. Sci Transl Med (2009) 1.94
Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome. J Comp Neurol (2004) 1.92
Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. Prog Clin Biol Res (1990) 1.84
Digging and marble burying in mice: simple methods for in vivo identification of biological impacts. Nat Protoc (2006) 1.80
Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci U S A (2001) 1.72
A behavioral assessment of Ts65Dn mice: a putative Down syndrome model. Neurosci Lett (1995) 1.70
Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome. Neuropharmacology (1998) 1.63
The epidemiology of obsessive-compulsive disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am (1999) 1.62
Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice. Hum Mol Genet (2007) 1.57
Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn. Mamm Genome (2011) 1.47
The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J Neurosci (2009) 1.46
A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions. Hum Mol Genet (2010) 1.42
Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors. J Am Acad Child Adolesc Psychiatry (1995) 1.41
Understanding the basis for Down syndrome phenotypes. PLoS Genet (2006) 1.41
Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships. J Comp Neurol (2007) 1.38
Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome. Neurosci Lett (2005) 1.36
Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test. Neuropsychopharmacology (2007) 1.35
Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome. J Comp Neurol (2009) 1.31
A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants. Eur J Pharmacol (2006) 1.29
The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome. J Neural Transm Suppl (1999) 1.28
Down syndrome: searching for the genetic culprits. Dis Model Mech (2011) 1.28
Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr Res (2000) 1.26
Practitioner review: short-term and working memory impairments in neurodevelopmental disorders: diagnosis and remedial support. J Child Psychol Psychiatry (2006) 1.22
Behavioral comparison of 4 and 6 month-old Ts65Dn mice: age-related impairments in working and reference memory. Behav Brain Res (2003) 1.21
A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome. Hum Mol Genet (2009) 1.20
Motor dysfunction in a mouse model for Down syndrome. Physiol Behav (2000) 1.19
Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome. Mamm Genome (2011) 1.19
Psychiatric disorders in persons with Down syndrome. J Nerv Ment Dis (1991) 1.18
Preservation of long-term memory and synaptic plasticity despite short-term impairments in the Tc1 mouse model of Down syndrome. Learn Mem (2008) 1.18
Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists. J Neurosci (2012) 1.17
Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice. J Psychopharmacol (2011) 1.16
Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome. Neurosci Lett (1998) 1.16
Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome. Neuropharmacology (2005) 1.15
Spatial memory deficits in segmental trisomic Ts65Dn mice. Behav Brain Res (1996) 1.12
Down syndrome: the brain in trisomic mode. Nat Rev Neurosci (2012) 1.10
Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndrome. PLoS One (2013) 1.10
Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer. Neurobiol Dis (2011) 1.09
Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome. Behav Brain Res (2010) 1.09
Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function. Behav Brain Res (2001) 1.09
Impairments in motor coordination without major changes in cerebellar plasticity in the Tc1 mouse model of Down syndrome. Hum Mol Genet (2009) 1.09
Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome. EMBO J (1992) 1.08
Genomic neighbourhood and the regulation of gene expression. Curr Opin Cell Biol (2010) 1.06
The use of mouse models to understand and improve cognitive deficits in Down syndrome. Dis Model Mech (2011) 1.05
Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome. Neurobiol Dis (2011) 1.05
Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice. Brain Res (2010) 1.05
Experimental parameters affecting the Morris water maze performance of a mouse model of Down syndrome. Behav Brain Res (2004) 1.04
Long-term memory in mental retardation: evidence for a specific impairment in subjects with Down's syndrome. Neuropsychologia (1997) 1.03
Impaired spatial working and reference memory in segmental trisomy (Ts65Dn) mice. Behav Brain Res (1998) 1.02
Investigative burying by laboratory mice may involve non-functional, compulsive, behaviour. Behav Brain Res (1998) 1.02
Neurological phenotypes for Down syndrome across the life span. Prog Brain Res (2012) 0.98
Spontaneous stereotypy in an animal model of Down syndrome: Ts65Dn mice. Behav Genet (2001) 0.97
Growth of children with Down's syndrome: birth to age 3 years. Pediatrics (1978) 0.95
Mouse models for Down syndrome-associated developmental cognitive disabilities. Dev Neurosci (2011) 0.95
Understanding mental retardation in Down's syndrome using trisomy 16 mouse models. Genes Brain Behav (2003) 0.95
Implicit and explicit memory: a functional dissociation in persons with Down syndrome. Neuropsychologia (2000) 0.95
Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage. Neurobiol Dis (2014) 0.95
Three-dimensional synaptic ultrastructure in the dentate gyrus and hippocampal area CA3 in the Ts65Dn mouse model of Down syndrome. J Comp Neurol (2011) 0.94
Trisomy of the G protein-coupled K+ channel gene, Kcnj6, affects reward mechanisms, cognitive functions, and synaptic plasticity in mice. Proc Natl Acad Sci U S A (2012) 0.94
On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models. Brain Res Brain Res Rev (2001) 0.94
Murine models for Down syndrome. Physiol Behav (2001) 0.93
Differential effects of trisomy on brain shape and volume in related aneuploid mouse models. Am J Med Genet A (2007) 0.93
Traumatic brain injury enhances neuroinflammation and lesion volume in caveolin deficient mice. J Neuroinflammation (2014) 0.93
Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms. Neurosci Res (2007) 0.93
Neurobehavioral disorders in children, adolescents, and young adults with Down syndrome. Am J Med Genet C Semin Med Genet (2006) 0.91
Working memory and Down syndrome. J Intellect Disabil Res (2007) 0.91
Behavioral, cognitive and biochemical responses to different environmental conditions in male Ts65Dn mice, a model of Down syndrome. Behav Brain Res (2005) 0.91
[Chromosomic diagnosis of mongolism]. Arch Fr Pediatr (1959) 0.90
Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome. J Alzheimers Dis (2010) 0.90
Gene-dosage effects in Down syndrome and trisomic mouse models. Genome Biol (2004) 0.89
Down syndrome and the phonological loop: the evidence for, and importance of, a specific verbal short-term memory deficit. Downs Syndr Res Pract (1999) 0.89
Behavioral characterization of a mouse model overexpressing DSCR1/ RCAN1. PLoS One (2011) 0.89
Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome. PLoS One (2014) 0.87
Impaired sustained attention and error-induced stereotypy in the aged Ts65Dn mouse: a mouse model of Down syndrome and Alzheimer's disease. Behav Neurosci (2004) 0.87
Medical conditions and medication use in adults with Down syndrome: a descriptive analysis. Downs Syndr Res Pract (2008) 0.87
Cognition and hippocampal plasticity in the mouse is altered by monosomy of a genomic region implicated in Down syndrome. Genetics (2014) 0.87
Object recognition memory is conserved in Ts1Cje, a mouse model of Down syndrome. Neurosci Lett (2007) 0.86
Dentate gyrus mediates cognitive function in the Ts65Dn/DnJ mouse model of Down syndrome. Hippocampus (2013) 0.86
Working memory and cognitive skills in individuals with Down syndrome. Child Neuropsychol (2009) 0.86
Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down's syndrome. J Neurosci (2014) 0.86
Animal models with potential applications for screening compounds for the treatment of obsessive-compulsive disorder. Expert Opin Investig Drugs (1997) 0.85
Brief report: obsessive-compulsive disorder in adults with Down's Syndrome. J Autism Dev Disord (1995) 0.84
Down syndrome and attention-deficit/hyperactivity disorder (ADHD). J Child Neurol (2011) 0.84
Movement disorder in Down's syndrome: a possible marker of the severity of mental handicap. Mov Disord (1996) 0.84
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. Biol Psychiatry (2009) 0.84
Discoveries in Down syndrome: moving basic science to clinical care. Prog Brain Res (2012) 0.83
Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits. Hum Mol Genet (2013) 0.83